
businessMar 31, 202032:40pending
Coronavirus Tests and Vaccines: Ammunition in the War Against COVID-19
Get every episode summarized
Each time Leadership Next publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Can business rise to meet the challenges presented by COVID-19? Can supply chains provide the medical equipment doctors and patients need? When will we have adequate coronavirus tests? And ultimately, how close are we to finding a vaccine for the disease? Those are the questions Alan Murray is asking on this week's Leadership Next. Today’s guests are two CEOs working overtime to provide the answers.
Up first, Alex Gorsky, CEO of Johnosn and Johnson. His company has just announced it will begin testing and manufacturing a vaccine that may be available early next year.
Also adding insight is Stan Bergman, the CEO of Henry Schein, a dental and medical supply company. Not only does the company supply healthcare workers with disposable masks, gloves, and gowns, it's working to bring COVID-19 point-of-care tests to these workers.
Get every episode summarized
Each time Leadership Next publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Leadership Next

2025 Recap: CEOs discuss embracing AI, tracking wellness, and marketing for Gen...
Leadership Next
Dec 30, 202516:23pending

Expedia’s CEO on the U.S. tourism slowdown, AI, and 2026 travel predictions | Le...
Leadership Next
Dec 23, 202530:11pending

Ad legend Dani Richa on AI, risk taking, and how advertising has changed
Leadership Next
Dec 17, 202535:18pending

Why Circle’s CEO Says Stablecoin Regulation Is Essential | Leadership Next
Leadership Next
Dec 9, 202534:48pending